292 related articles for article (PubMed ID: 26428847)
1. Increased Tim-3 expression in peripheral NK cells predicts a poorer prognosis and Tim-3 blockade improves NK cell-mediated cytotoxicity in human lung adenocarcinoma.
Xu L; Huang Y; Tan L; Yu W; Chen D; Lu C; He J; Wu G; Liu X; Zhang Y
Int Immunopharmacol; 2015 Dec; 29(2):635-641. PubMed ID: 26428847
[TBL] [Abstract][Full Text] [Related]
2. Tim-3 expression by peripheral natural killer cells and natural killer T cells increases in patients with lung cancer--reduction after surgical resection.
Xu LY; Chen DD; He JY; Lu CC; Liu XG; Le HB; Wang CY; Zhang YK
Asian Pac J Cancer Prev; 2014; 15(22):9945-8. PubMed ID: 25520133
[TBL] [Abstract][Full Text] [Related]
3. Tim-3 expression on peripheral monocytes and CD3+CD16/CD56+natural killer-like T cells in patients with chronic hepatitis B.
Rong YH; Wan ZH; Song H; Li YL; Zhu B; Zang H; Zhao Y; Liu HL; Zhang AM; Xiao L; Xin SJ; You SL
Tissue Antigens; 2014 Feb; 83(2):76-81. PubMed ID: 24397461
[TBL] [Abstract][Full Text] [Related]
4. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B.
Ju Y; Hou N; Meng J; Wang X; Zhang X; Zhao D; Liu Y; Zhu F; Zhang L; Sun W; Liang X; Gao L; Ma C
J Hepatol; 2010 Mar; 52(3):322-9. PubMed ID: 20133006
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated Expression of Tim-3 and NKp30 Receptors on NK Cells of Patients with Chronic Lymphocytic Leukemia.
Hadadi L; Hafezi M; Amirzargar AA; Sharifian RA; Abediankenari S; Asgarian-Omran H
Oncol Res Treat; 2019; 42(4):202-208. PubMed ID: 30870839
[TBL] [Abstract][Full Text] [Related]
6. Distribution of several activating and inhibitory receptors on CD3(-)CD56(+) NK cells in regional lymph nodes of melanoma patients.
Vuletić A; Jurišić V; Jovanić I; Milovanović Z; Nikolić S; Konjević G
J Surg Res; 2013 Aug; 183(2):860-8. PubMed ID: 23522458
[TBL] [Abstract][Full Text] [Related]
7. Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity.
Ndhlovu LC; Lopez-Vergès S; Barbour JD; Jones RB; Jha AR; Long BR; Schoeffler EC; Fujita T; Nixon DF; Lanier LL
Blood; 2012 Apr; 119(16):3734-43. PubMed ID: 22383801
[TBL] [Abstract][Full Text] [Related]
8. [Expression of Tim-3 on Peripheral CD56(+) NK Cells and ItsCorrelation with Liver Fibrosis in Patients withAdvanced Schistosomiasis].
WU QW; ZHU X; FU X; YANG JS; CAO ZG; PU C
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2015 Oct; 33(5):346-50. PubMed ID: 26931038
[TBL] [Abstract][Full Text] [Related]
9. Expression of immune checkpoint molecules of T cell immunoglobulin and mucin protein 3/galectin-9 for NK cell suppression in human gastrointestinal stromal tumors.
Komita H; Koido S; Hayashi K; Kan S; Ito M; Kamata Y; Suzuki M; Homma S
Oncol Rep; 2015 Oct; 34(4):2099-105. PubMed ID: 26239720
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of T cell immunoglobulin- and mucin domain-containing molecule-3 on natural killer cells in atherogenesis.
Hou N; Zhao D; Liu Y; Gao L; Liang X; Liu X; Gai X; Zhang X; Zhu F; Ni M; Zhang Y; Sun W; Ma C
Atherosclerosis; 2012 May; 222(1):67-73. PubMed ID: 22387059
[TBL] [Abstract][Full Text] [Related]
11. Tim-3 Is Upregulated in NK Cells during Early Pregnancy and Inhibits NK Cytotoxicity toward Trophoblast in Galectin-9 Dependent Pathway.
Sun J; Yang M; Ban Y; Gao W; Song B; Wang Y; Zhang Y; Shao Q; Kong B; Qu X
PLoS One; 2016; 11(1):e0147186. PubMed ID: 26789128
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cell subsets and receptor expression in peripheral blood mononuclear cells of a healthy Korean population: Reference range, influence of age and sex, and correlation between NK cell receptors and cytotoxicity.
Phan MT; Chun S; Kim SH; Ali AK; Lee SH; Kim S; Kim SH; Cho D
Hum Immunol; 2017 Feb; 78(2):103-112. PubMed ID: 27884732
[TBL] [Abstract][Full Text] [Related]
13. CD56(+dim) and CD56(+bright) cell activation and apoptosis in hepatitis C virus infection.
Lin AW; Gonzalez SA; Cunningham-Rundles S; Dorante G; Marshall S; Tignor A; Ha C; Jacobson IM; Talal AH
Clin Exp Immunol; 2004 Aug; 137(2):408-16. PubMed ID: 15270860
[TBL] [Abstract][Full Text] [Related]
14. TNF-α-induced Tim-3 expression marks the dysfunction of infiltrating natural killer cells in human esophageal cancer.
Zheng Y; Li Y; Lian J; Yang H; Li F; Zhao S; Qi Y; Zhang Y; Huang L
J Transl Med; 2019 May; 17(1):165. PubMed ID: 31109341
[TBL] [Abstract][Full Text] [Related]
15. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of natural killer cells and CD56+ T-cells in sarcoidosis patients.
Katchar K; Söderström K; Wahlstrom J; Eklund A; Grunewald J
Eur Respir J; 2005 Jul; 26(1):77-85. PubMed ID: 15994392
[TBL] [Abstract][Full Text] [Related]
17. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M
Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416
[TBL] [Abstract][Full Text] [Related]
18. Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C.
Bonorino P; Ramzan M; Camous X; Dufeu-Duchesne T; Thélu MA; Sturm N; Dariz A; Guillermet C; Pernollet M; Zarski JP; Marche PN; Leroy V; Jouvin-Marche E
J Hepatol; 2009 Sep; 51(3):458-67. PubMed ID: 19596474
[TBL] [Abstract][Full Text] [Related]
19. Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9.
Gleason MK; Lenvik TR; McCullar V; Felices M; O'Brien MS; Cooley SA; Verneris MR; Cichocki F; Holman CJ; Panoskaltsis-Mortari A; Niki T; Hirashima M; Blazar BR; Miller JS
Blood; 2012 Mar; 119(13):3064-72. PubMed ID: 22323453
[TBL] [Abstract][Full Text] [Related]
20. [Expression of Tim-3 on natural killer cells in patients with acute myeloid leukemia and its clinical significance].
Ma JF; Li CX; Wu DP; Sun ZL; Yan CL
Zhonghua Xue Ye Xue Za Zhi; 2019 Sep; 40(9):755-758. PubMed ID: 31648478
[No Abstract] [Full Text] [Related]
[Next] [New Search]
